Announcements Trials
Browse Landscape

Phase

Phase 1 6Phase 1/2 5Phase EARLY_PHASE1 1

Status

Recruiting 4Not yet recruiting 1Active not recruiting 1

Sponsor Class

INDUSTRY 6

Study Type

Interventional 6

Sponsor

Conditions

Carcinoma, Non-Small-Cell Lung 373Neoplasms 323Neoplasm Metastasis 286Leukemia, Myeloid, Acute 277Breast Neoplasms 271Colorectal Neoplasms 238Melanoma 193Ovarian Neoplasms 191Recurrence 183Multiple Myeloma 178Prostatic Neoplasms 156Lung Neoplasms 156Pancreatic Neoplasms 152Squamous Cell Carcinoma of Head and Neck 150Lymphoma, Non-Hodgkin 146Glioblastoma 145Triple Negative Breast Neoplasms 119Myelodysplastic Syndromes 114Carcinoma, Renal Cell 111Stomach Neoplasms 110Glioma 108Brain Neoplasms 105Advanced Solid Tumors 104Precursor Cell Lymphoblastic Leukemia-Lymphoma 103Lymphoma, Large B-Cell, Diffuse 101Lymphoma 100Lymphoma, B-Cell 97Carcinoma, Hepatocellular 95Endometrial Neoplasms 92Lymphoma, Follicular 91

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

6 trials
RecentStart dateEnrollment
Phase 1 × Advanced Malignant Tumors × 1 year × Clear all
NCT06167486 2026-03-09

SG2918 For Advanced Malignant Tumors

Hangzhou Sumgen Biotech Co., Ltd.

Phase 1 Active not recruiting
17 enrolled

Advanced Malignant Tumors

NCT07038005 2026-02-09

A Phase I Study of SPGL008 in Subjects With Advanced Malignant Tumors

Shenyang Sunshine Pharmaceutical Co., LTD.

Phase 1 Recruiting
96 enrolled

Advanced Malignant Tumors

NCT07016490 2026-01-28

A Phase 1 Study of SSGJ-709 in Patients With Advanced Malignant Tumors

Shenyang Sunshine Pharmaceutical Co., LTD.

Phase 1 Recruiting
15 enrolled

Advanced Malignant Tumors

NCT07043751 2026-01-21

A Clinical Trial Evaluating Injection of TQB6411 in Subjects With Advanced Malignant Tumors

Chia Tai Tianqing Pharmaceutical Group Co., Ltd.

Phase 1 Recruiting
216 enrolled

Advanced Malignant Tumors

NCT07338838 2026-01-14

To Evaluate the Tolerability and Pharmacokinetics of TQB3142 for Injection in Patients With Advanced Malignant Tumors

Chia Tai Tianqing Pharmaceutical Group Co., Ltd.

Phase 1 Not yet recruiting
66 enrolled

Advanced Malignant Tumors

NCT07032298 2025-07-25

A Phase I Study of SSGJ-612 in Patients With Advanced Solid Tumors

Shenyang Sunshine Pharmaceutical Co., LTD.

Phase 1 Recruiting
30 enrolled

Advanced Malignant Tumors

Data powered by HemOnc (CC BY 4.0) Colophon âš¡